Aug 27, 2025
608:517
For every 517 shares held, investors received 608. The price per share adjusted from $50.90 to $43.28.
The split itself did not change the total investment value.
Diamond Biotechnology Co., Ltd. (TPEX:6815) operates in the Medical specialties industry.
Diamond Biotechnology Co., Ltd. company overviewDiamond Biotechnology Co., Ltd.'s most recent stock split was on August 27, 2025. It was a 608-for-517 forward split, so shareholders received 608 shares for every 517 they held.
Diamond Biotechnology Co., Ltd. (TPEX:6815) has split its stock 6 times: a 742-for-711 split on August 27, 2021, a 1023-for-883 split on August 24, 2022, a 61-for-55 split on August 23, 2023, a 909-for-898 split on April 25, 2024, a 501-for-446 split on August 5, 2024, and a 608-for-517 split on August 27, 2025.
Diamond Biotechnology Co., Ltd. has split its stock 6 times. This history records 6 forward splits between August 27, 2021 and August 27, 2025.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Diamond Biotechnology Co., Ltd.'s 608-for-517 split on August 27, 2025, every 517 shares became 608 shares.
Diamond Biotechnology Co., Ltd. has not announced a new split in our records. Its most recent split was on August 27, 2025, 1 year ago. Companies announce splits in advance, and any new TPEX:6815 split will appear on this page.
Already premium?